INTRODUCTION
Tracking describes the stability of a measurement relative to the population distribution over time. As such, if a biological marker is known to track highly, one measurement can be used to predict future measurements and, therefore, inform the need for interventions to prevent high or low levels. (3) (4) (5) . However, it is well recognized that, at latitudes far from the equator, 25(OH)D displays a seasonal variation at the population level (6, 7) . To our knowledge, there are no data in any population group that have shown the tracking of an individual's 25(OH)D concentration within the population distribution after taking account of the seasonal variation. This research might be of particular relevance during pregnancy when the delineation of trimester specific effects has major practical relevance.
There is a wealth of observational data from studies that assessed the relations between maternal serum 25(OH)D and obstetric complications and offspring development (2, 8) . These studies have not consistently shown that higher serum 25(OH)D in pregnancy is associated with improved clinical outcomes for either the mother or offspring. However, the timing of a maternal 25(OH)D measurement varies between data sets from early gestation to delivery and across seasons, and this adds complexity to the comparison of results from different studies. Despite the few data available from intervention studies that have shown clinical benefits of antenatal vitamin D supplementation (2, 8) , many national guidelines recommend vitamin D supplementation to all women in pregnancy (9-11). As such, the knowledge regarding the tracking of 25(OH)D during pregnancy might enable a clearer interpretation and comparison of studies with inconsistent findings for the same outcome and may influence the development of future supplementation policies. Therefore, we assessed the tracking of 25(OH)D from early to late pregnancy in the SWS (Southampton Women's Survey), which is a prospective mother-offspring birth-cohort study. In addition, we explored maternal factors that might influence 25(OH)D tracking.
METHODS

The SWS
Details of the study have previously been published (12) but, briefly, the SWS is a population-based, prospective, motheroffspring birth-cohort study that is based in Southampton, United Kingdom (latitude: 50.98N). Nonpregnant women aged 20-34 y were recruited into the study between April 1998 and October 2002 (n = 12,583) and asked to inform the research center if they became pregnant. The SWS was conducted according to the guidelines of the Declaration of Helsinki, and the Southampton and South West Hampshire Research Ethics Committee approved all procedures (276/97 and 307/97). Written informed consent was obtained from all participating women. The SWS is registered in the Cohort and Longitudinal Studies Enhancement Resources, at birthcohort.net, and in the United Kingdom Medical Research Council cohort directory.
Maternal data
At the prepregnancy interview, details of maternal parity, highest educational attainment, and ethnicity were obtained, and height and weight were measured. For women who became pregnant, assessments were performed at 11 (early pregnancy) and 34 (late pregnancy) wk of gestation. Information on smoking status, alcohol intake, exercise participation, and dietary supplement use was obtained from an interview-administered health and lifestyle questionnaire. Information collected regarding vitamin D supplementation included the brand of supplements used and the frequency of use. The manufacturer's information was used to determine the vitamin D content of the supplements. A validated 100-item food-frequency questionnaire was used to assess dietary intake (13) , and from this questionnaire, dietary vitamin D intake was determined by multiplying the frequency of consumption of a portion of each food by its vitamin D content according to the United Kingdom food-composition tables or manufacturers' composition data.
25(OH)D analysis
Nonfasted venous blood samples were obtained at 11 and 34 wk of gestation, and an aliquot of maternal serum was stored at 2808C. All early pregnancy 25 3 for both early and late pregnancy. The laboratories that undertook both analyses are members of the Vitamin D External Quality Assurance scheme, and both assays met the requirements of this scheme. Intra-assay and interassay CVs for both methods were ,10%.
Statistical analysis
Maternal characteristics for women with and without serum 25(OH)D status in pregnancy were compared with the use of t, Mann-Whitney U, and chi-square tests for normally distributed, nonnormally distributed, and categorical outcomes, respectively. Fourier transformations were used to model the seasonal variation in log e [25 (14) . A Bland-Altman plot was also used to assess the agreement between season-corrected 25(OH)D in early and late pregnancy (15) . Maternal factors that were associated with the change in season-corrected 25(OH)D were assessed with the use of simple linear regression, and predictors with P , 0.20 were included in a multiple linear regression model. Finally, we assessed differences in maternal characteristics according to vitamin D-supplement use with an ANOVA and chi-square test.
All analyses was performed in Stata software (v13; StataCorp LP). P , 0.05 was considered statistically significant.
RESULTS
A total of 3158 women who were participating in the SWS delivered a liveborn singleton infant. Serum 25(OH)D concentration was assessed in 2019 women (64.0%) and 2328 women (73.7%) in early and late pregnancy, respectively. A total of 1753 women had 25(OH)D measured in both early and late pregnancy. Characteristics of these women are shown in Table 1 . Compared with women who delivered a live birth in the study but who did not have 25(OH)D measured in both early and late pregnancy, the women included in this analysis were younger, of higher parity, and less likely to have smoked in early pregnancy (Table 1) .
Seasonal modeling of 25(OH)D in pregnancy
In both early pregnancy and late pregnancy, 25(OH)D displayed significant seasonal variation (Figure 1) . The Fourierseries model explained 17% (P , 0.0001) and 30% (P , 0.0001) of the variance in 25(OH)D in early and late pregnancy, respectively. The mean 6 SD difference between measured 25(OH)D and that modeled by the Fourier series for the date of sampling in early pregnancy was 4.6 6 23.3 nmol/L (range: 261.2 to 146.0 nmol/L) and that in late pregnancy was 4.8 6 25.7 nmol/L (range: 266.2 to 182.7 nmol/L).
Tracking of 25(OH)D status from early to late pregnancy
The correlation coefficient between measured 25(OH)D in early and late pregnancy was low (r = 0.21; 95% CI: 0.17, 0.26; Figure 2 ). However, season-corrected 25(OH)D was more highly correlated from early to late pregnancy (r = 0.53; 95% CI: 0.50, 0.57; Figure 2 ). Figure 3 illustrates the agreement between the season-corrected 25(OH)D in early and late pregnancy with the use of a Bland-Altman plot.
Maternal determinants of change in season-corrected 25(OH)D
A number of maternal factors were associated with the change in season-corrected 25(OH)D (Table 2) , but only the timing of maternal vitamin D-supplementation use, exercise in late pregnancy, and pregnancy weight gain remained significantly associated in the multivariate analysis (Table 2) . Thus, compared with women who never took supplements, the discontinuation of vitamin D supplements after early pregnancy blood sampling was negatively associated with the change in season-corrected 25(OH)D (b = 27.3 nmol/L; P , 0.001), whereas the continuation (b = 12.6 nmol/L; P , 0.001) or start of supplementation (b = 6.6 nmol/L; P , 0.001) was positively associated with the change in season-corrected 25(OH)D. Women who either never started or discontinued taking supplements during pregnancy were younger, less-well educated, more likely to smoke in early pregnancy, and less likely to be in their first pregnancy than were women who continued supplementation throughout pregnancy ( Table 3) .
DISCUSSION
In this large prospective cohort study, we have shown that there was moderate tracking of serum 25(OH)D status from early to late pregnancy, and the change in deviation from the modeled (16) (17) (18) , but the findings have been contradictory. However, the interpretation of these studies has been limited by the recruitment of all women during the same season or insufficient account having been taken of the season of blood sampling. Furthermore, none of these studies considered tracking at the individual level. In nonpregnant adults, 3 studies have shown high levels of 25(OH)D tracking when measured in the same month over several years (3-5), although Hofmann et al. (5) showed that the correlation coefficient was reduced with an increasing number of years between sampling.
Our finding could have an important clinical use; in combination with population data across seasons, a single measurement of 25(OH)D could be used to identify women who are at risk of low concentrations of 25(OH)D at other stages of pregnancy. Thus, appropriate counseling regarding the need for vitamin D supplementation could be provided.
We observed that changes in supplement use strongly influenced 25(OH)D stability relative to the population distribution. Women who either did not use vitamin D supplementation or stopped supplementation after early pregnancy were younger, less-well educated, more likely to smoke, and less likely to be in their first pregnancy and had higher prepregnancy BMI. Previous cross-sectional studies have identified that younger age (19), higher BMI or weight (20) (21) (22) , smoking (6, (20) (21) (22) , and lower educational achievement (20) increase risk of vitamin D deficiency in pregnancy, whereas a higher parity is protective (22) . Although the majority of women in this study were pregnant before the publication of the United Kingdom Department of Health guidelines that suggest that all women should receive vitamin D supplementation in pregnancy (9), similar demographic factors have also been associated with a reduced likelihood of folic acid supplementation during pregnancy (23, 24) . Therefore, there findings highlight a group of women who might require additional health education during early pregnancy.
In addition, we showed that greater weight gain during pregnancy and less exercise in late pregnancy were associated with the downward tracking of 25(OH)D. Adiposity is negatively associated with 25(OH)D in nonpregnant populations, and this association has been hypothesized to result from the sequestration of 25(OH)D within adipose tissue (25) . Indeed, vitamin D-supplementation studies have shown that the incremental rise in 25(OH)D was lower in obese individuals than in nonobese individuals (26, 27) , whereas, conversely, weight loss was associated positively with the change in 25(OH)D (28) (29) (30) . Thus, although we cannot be certain that greater weight gain represents increased fat mass as opposed to fetoplacental tissues, it is likely that the downward tracking of 25(OH)D reflects a higher volume of dilution. Furthermore, this finding suggests that women who gain greater weight in pregnancy might require higher supplementation doses to prevent vitamin D deficiency. This possibility needs to be established in intervention studies.
The strength of this study was in the detailed phenotyping and large number of women included. However, there were a number of limitations that should be considered when interpreting the study. First, the women who participated in the SWS who did not have blood sampling in both early and late pregnancy were older and were more likely to be of nonwhite ethnicity, to be in their first pregnancy, and to smoke in early pregnancy. Therefore, these women were at higher risk of vitamin D deficiency, and our findings are likely to be of particular relevance to this group. It is also likely that the inclusion of such women would have increased the number at the lower end of the 25(OH)D distribution and, thus, yielded greater statistical power. Therefore, although there may be limitations to the generalizability of our finding, there is no reason, to our knowledge, to suppose that the associations observed would have been materially affected. Our findings suggest that women who are at high risk of vitamin D deficiency should be informed that they are likely to remain vitamin D deficient throughout pregnancy unless approaches to increasing their 25(OH)D status are implemented. Second, the women were recruited over a 4-y period. The Fourier transformation used to model the seasonal variation in 25(OH)D assumed that this is the same for each year. However, because of the year-to-year differences in weather, it was unlikely that the pattern was identical every year. Nonetheless, the effect of season was highly significant and accounted for 17-30% of the variation in 25(OH)D. Third, 25(OH)D was measured with different assays in early and late pregnancy with the use of stored, frozen serum samples. However, each model was generated only on the basis of a single assay in a laboratory that was a member of the Vitamin D External Quality Assurance scheme, and therefore, it was unlikely that the use of different assays in early and late pregnancy would have affected the rank change or the tracking coefficient. Furthermore, it has been previously shown that the storage of serum at 2808C does not affect the stability of 25(OH)D (31) . Nonetheless, a graphical representation of the seasonal models of 25(OH)D suggested a higher summer-time peak and a more-flattened winter trough in late pregnancy than in early pregnancy. We cannot be certain whether this was a pregnancy-induced effect or was due to assay differences, and indeed, care should be taken when translating these findings to other populations. Finally, we did not obtain information on the time spent outdoors or on holidays abroad and how this changed during pregnancy.
In conclusion, in this study, we have shown the moderate tracking of 25(OH)D status during pregnancy, which could be used to predict the likelihood of an individual developing low concentrations of 25(OH)D during pregnancy. High-quality Differences in maternal characteristics according to vitamin D-supplement use were assessed with an ANOVA and chi-square test for continuous and categorical data, respectively. Prepregnancy BMI was not normally distributed; therefore, significance was determined with the use of the log of this variable. All associations from the univariate analysis with P # 0.2 were included in the multivariable model. 4 All associations were significant.
randomized controlled trials are needed to show whether antenatal vitamin D supplementation can affect clinical outcomes (1, 32) . If so, a number of maternal characteristics that have been associated with both 25(OH)D status and the use of supplementation currently exist and should be considered in the provision of public health advice.
